Results of Phase 3 Trial Evaluating the Efficacy and Safety of #Merck $MRK’s RECARBRIO™ (Imipenem, Cilastatin, and Relebactam) Versus Piperacillin and Tazobactam in Adult Patients with HABP/VABP Now Available https://t.co/QW5f8PiGBy